TY - JOUR
T1 - c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion
AU - Hayashi, Takeshi
AU - Sakai, Ken Ichi
AU - Sasaki, Chihoko
AU - Zhang, Wen Ri
AU - Warita, Hitoshi
AU - Abe, Koji
N1 - Funding Information:
This work was partly supported by Grant-in-Aid for Scientific Research (A)10176204 and (B) 09470151 from the Ministry of Education, Science and Culture of Japan, by a Grant (K. Tashiro) from the Ministry of Health and Welfare of Japan, Suzuken Memorial Sciences Foundation, and by Japan Heart Foundation Dr Hiroshi Irisawa Commemorative Research Grant.
PY - 2000/4/28
Y1 - 2000/4/28
N2 - c-Jun response is involved in the development of ischemic brain injury, which is activated by c-Jun N-terminal kinase-1 (JNK-1). The activity of JNK-1 is strictly regulated, and only the phosphorylated form of JNK (phospho-JNK) which is translocated to the nucleus has an ability to activate c-Jun response. There is a protein which inhibits JNK-1 activation, and known as JNK interacting protein-1 (JIP-1). In this study, we investigated change in JNK-1, phospho-JNK, and JIP-1 immunoreactivity in rat brain after transient middle cerebral artery (MCA) occlusion. Immunoreactive JNK-1 was scant in the sham-control brain, but it was induced at 1 h after reperfusion, which was slightly increased at 3 h of reperfusion. By contrast, phospho-JNK remained negative till 3 h. At 8 h, JNK-1 and phospho-JNK became distinctly positive, and nuclei as well as cytoplasm were stained. Thereafter, immunoreactivity for JNK-1 and phospho-JNK became furthermore dense, and most neurons revealed positively stained nuclei. Immunoreactivity for JIP-1 remained negative till 8 h of reperfusion, but at 24 and 72 h, cytoplasm of cortical neurons at the MCA boundary area was positively stained. This JIP-1 induction got behind the JNK-1 activation, and therefore, may be a vain effort for neurons to survive. Inhibition of JNK-1 activation might become an innovative means of therapy for stroke treatment in the future. Copyright (C) 2000 Elsevier Science Ireland Ltd.
AB - c-Jun response is involved in the development of ischemic brain injury, which is activated by c-Jun N-terminal kinase-1 (JNK-1). The activity of JNK-1 is strictly regulated, and only the phosphorylated form of JNK (phospho-JNK) which is translocated to the nucleus has an ability to activate c-Jun response. There is a protein which inhibits JNK-1 activation, and known as JNK interacting protein-1 (JIP-1). In this study, we investigated change in JNK-1, phospho-JNK, and JIP-1 immunoreactivity in rat brain after transient middle cerebral artery (MCA) occlusion. Immunoreactive JNK-1 was scant in the sham-control brain, but it was induced at 1 h after reperfusion, which was slightly increased at 3 h of reperfusion. By contrast, phospho-JNK remained negative till 3 h. At 8 h, JNK-1 and phospho-JNK became distinctly positive, and nuclei as well as cytoplasm were stained. Thereafter, immunoreactivity for JNK-1 and phospho-JNK became furthermore dense, and most neurons revealed positively stained nuclei. Immunoreactivity for JIP-1 remained negative till 8 h of reperfusion, but at 24 and 72 h, cytoplasm of cortical neurons at the MCA boundary area was positively stained. This JIP-1 induction got behind the JNK-1 activation, and therefore, may be a vain effort for neurons to survive. Inhibition of JNK-1 activation might become an innovative means of therapy for stroke treatment in the future. Copyright (C) 2000 Elsevier Science Ireland Ltd.
KW - C-Jun N-terminal kinase
KW - C-Jun N-terminal kinase interacting protein
KW - Immunohistochemistry
KW - Ischemia
KW - Rat
UR - http://www.scopus.com/inward/record.url?scp=0034724978&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034724978&partnerID=8YFLogxK
U2 - 10.1016/S0304-3940(00)01024-7
DO - 10.1016/S0304-3940(00)01024-7
M3 - Article
C2 - 10773432
AN - SCOPUS:0034724978
SN - 0304-3940
VL - 284
SP - 195
EP - 199
JO - Neuroscience Letters
JF - Neuroscience Letters
IS - 3
ER -